You are on page 1of 2

ELECTRONIC IMAGE OF THE MONTH

Prolapsed Gastric Gastrointestinal Stromal Tumor: A Rare Cause


of Biliary Obstruction and Acute Pancreatitis
Musa Yilmaz, Juan Ibarra, and Benjamin Leon Musher

Baylor College of Medicine, Houston, Texas

77-year-old woman presented with abdominal Comprising fewer than 1% of all gastrointestinal
A pain and early satiety. Computed tomography
of the abdomen (Figure A) showed a 6-cm submucosal
tumors, GISTs are intramucosal spindle-cell neoplasms
that can arise throughout the gastrointestinal tract
mass (white arrow) on a stalk (black arrow) arising but are most commonly found in the stomach. Although
from the gastric fundus as well as several benign- they are frequently discovered incidentally, GISTs
appearing liver lesions. Esophagogastroduodenoscopy may cause early satiety, bloating, bleeding, pain, or
(Figure B) demonstrated the same non-friable, non- frank bowel obstruction. Our patient presented with
obstructing gastric mass (white arrow) and its stalk pancreatitis and biliary obstruction (manifested by
(black arrow). While biopsy results were pending, the elevated serum lipase and bilirubin levels and a
patient presented to the emergency department with radiographic “double-duct” sign) because of a pro-
acutely worsening abdominal pain, nausea, vomiting, lapsed GIST obstructing the ampulla of Vater. Although
and jaundice. Laboratory evaluation was significant gastric GISTs or polyps may infrequently prolapse
for the following: alanine aminotransferase 83 U/L, through the pylorus into the duodenum, to our
aspartate aminotransferase 117 U/L, total bilirubin knowledge there are only 2 published case reports of
4 mg/dL, and lipase 5315 U/L. Computed tomography gastric GIST causing pancreatitis2,3 and no published
imaging (Figure C) showed that the aforementioned reports of gastric GIST causing both pancreatitis and
mass had prolapsed into the duodenum (white arrow) biliary obstruction. After resection of a GIST, the
and obstructed the ampulla of Vater, resulting in dila- consulting oncologist can assess recurrence risk on the
tion of the common bile duct (white arrowhead), basis of tumor size, mitotic rate, and anatomic location1
pancreatic duct (black arrow), and gallbladder. The and, in turn, determine whether to recommend imati-
mass was resected surgically, and microscopic evalua- nib, which has been shown to improve recurrence-free
tion (Figure D) revealed a low-grade spindle-cell survival in patients with resected intermediate or high-
neoplasm expressing CD117 (KIT), which is consistent risk GIST.4
with a gastrointestinal stromal tumor (GIST). The
patient recovered well from surgery. Her serum bili-
rubin and lipase levels normalized, and postoperative References
imaging showed resolution of the pancreatobiliary 1. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathol-
ductal dilation. Because this GIST carried a low ogy and prognosis at different sites. Semin Diagn Pathol 2006;
(<5%) risk for recurrence on the basis of its size 23:70–83.
(5–10 cm), location (stomach), and low mitotic rate 2. Senadhi V, Arora D, Jani N. Gastrointestinal stromal tumor
(5 mitoses/50 high-power field), we did not recom- (GIST) presenting with acute pancreatitis. Endoscopy 2011;
mend any adjuvant therapy.1 43(Suppl 2 UCTN):E76.

Clinical Gastroenterology and Hepatology 2015;13:e35–e36


ELECTRONIC IMAGE OF THE MONTH, continued
3. Jones O, Monk D, Balling T, et al. Acute pancreatitis secondary to a
prolapsed gastric fundal GIST. Int J Surg Case Rep 2012;3:82–85. Conflicts of interest
The authors disclose no conflicts.
4. Dematteo RP, Ballman KV, Antonescu CR, et al. Adjuvant
imatinib mesylate after resection of localised, primary gastroin-
© 2015 by the AGA Institute
testinal stromal tumour: a randomised, double-blind, placebo- 1542-3565/$36.00
controlled trial. Lancet 2009;373:1097. http://dx.doi.org/10.1016/j.cgh.2014.09.037

e36

You might also like